MY ACCOUNT | NEWSLETTER |

Splenectomy in the management of primary immune-mediated hematological diseases


Current reports about the use of splenectomy for the management of immune-mediated hemolytic anemia (IMHA) or immune-mediated thrombocytopenia (ITP), or both, in dogs are limited. 

The authors of this study sought to retrospectively describe the use of splenectomy as part of the management for IMHA, ITP, and concurrent IMHA and severe thrombocytopenia (CIST) in dogs. It was hypothesized that splenectomy would be beneficial in allowing for reduction of dose of immunosuppressive drugs or discontinuation in one or more of these groups. 

Seventeen client-owned dogs (7 with IMHA, 7 with ITP and 3 with CIST) were identified across seven UK-based referral hospitals from a study period of 2005 to 2016. 

Data were collected retrospectively via questionnaires and included information about diagnosis, management, and treatment response before and after splenectomy. Based on clinical outcome, treatment with splenectomy as part of the management protocol was classified as either successful or unsuccessful. 

Six of seven dogs with ITP were managed successfully with splenectomy as part of their management protocol (3 complete and 3 partial responses), although one subsequently developed suspected IMHA. Of the seven dogs with IMHA, splenectomy was part of a successful management protocol in four dogs (2 complete and 2 partial responses). In the CIST group, one case (one of three) responded completely to management with splenectomy as part of the management protocol. 

Splenectomy was considered successful and well tolerated in most cases of isolated ITP. Whether there is a benefit of splenectomy in cases of IMHA and CIST could not be determined in the current study. 

Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.” Jason P Bestwick, et al. J Vet Intern Med. 2022 Jul 7.  doi: 10.1111/jvim.16469. 

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Sploot opens second clinic in Denver, with more on the way

Like0
Dislike0

Dr. Christopher Byers: The pandemic broke me

Like0
Dislike0

Disaster preparedness for animals

Like0
Dislike0

Echocardiographic indicators of fluid responsiveness in hospitalized dogs with compromised hemodynamics, tissue hypoperfusion

Like0
Dislike0

Morris Animal Foundation accepting RFPs to use golden retriever study data, samples

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2022 - All Rights Reserved
ISSN 2768-198X

Top